Prudent Q2 FY27: Consolidated PAT Up 34% YoY To ₹71.7 Cr As Margins Expand
PAT +33.92% YoY · revenue +21.56% · margins expanding · beat vs street
₹388.73 Cr
+21.56% YoY
₹71.7 Cr
+33.92% YoY
18.27%
+1.9pp YoY
₹17.32
Consolidated PAT came in at ₹71.70 Cr, up 33.9% YoY from ₹53.54 Cr, on revenue of ₹388.73 Cr, up 21.6% YoY from ₹319.79 Cr; basic EPS was ₹17.32 versus ₹12.93 a year ago. Against our pre-result preview, which flagged expected revenue of ₹340–360 Cr and PAT of ₹70–75 Cr with a Street consensus Buy (6-7 analysts, median target ₹3,050), the quarter beat on revenue and landed within the expected PAT band — consistent with the flows-and-margin story the Street was watching after Q1's 44% YoY PAT surge.
Q2 FY-2027 vs prior quarters
Operating margin (EBITDA/revenue-from-operations) expanded to 26.44% from 22.57% a year ago and from 25.62% in Q1 FY27, as commission-and-fee expense ran at 54.4% of revenue from operations — below the 56.2% steady-state management flagged on the July concall. Net profit margin, however, slipped sequentially to 18.27% from 20.29% in Q1 FY27 even as it expanded YoY from 16.32%. That QoQ dip is not an operating issue: other income fell to ₹3.80 Cr from an unusually elevated ₹20.83 Cr in Q1 FY27, and this swing alone accounts for the entire QoQ PAT decline (-4.1%, to ₹71.70 Cr from ₹74.76 Cr) despite revenue growing 11.8% QoQ — the core distribution business in fact grew PAT faster than revenue on a YoY basis.
The stock went into the print at ₹2,986, down 3.6% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Gross yield stabilized at 88 bps post-regulatory reset; no new revenue targets disclosed. Commission payout at 56.2% of revenue is steady-state. Employee cost guidance FY27: +22–24% growth. Treasury book ₹650 Cr available for accretive acquisitions. Plans ~30 branch additions in FY27.
— This quarter: met
On prior guidance, results are mixed: commission payout improved versus the guided steady-state, but employee benefit expense grew 30.8% YoY (₹43.08 Cr vs ₹32.95 Cr), running ahead of the 22-24% FY27 growth band guided last quarter. The 88 bps gross-yield level and the ~30-branch FY27 addition plan aren't verifiable from this filing, which carries no segment/AUM disclosure or accompanying press release — management's own framing of the quarter is absent from the document. Same-day board actions included a ₹6.53 Cr rights-issue investment into wholly-owned subsidiary Prutech Financial Services to meet SEBI portfolio-manager net-worth norms (a first visible draw on the ₹650 Cr acquisition treasury flagged last quarter) and a 1,190-share ESOP allotment at ₹2,632 exercise price.
W1
Employee cost growth running at 30.8% YoY vs the 22-24% FY27 guidance band — watch for moderation in H2 FY27
W2
Other income trajectory: ₹20.83 Cr in Q1 FY27 vs ₹3.80 Cr in Q2 FY27 — watch which level is the better run-rate indicator
W3
Deployment of the ₹650 Cr acquisition treasury beyond the ₹6.53 Cr Prutech investment committed this quarter
Figures in source are ₹ Lakh, converted to ₹ Cr; both checks (totalIncome≈revenue+otherIncome, PAT≈PBT−tax) tie out exactly for both statements; no exceptional items disclosed; two subsidiaries (combined assets ₹169.98 Cr, combined quarterly PAT ₹1.92 Cr) were reviewed by other auditors per the consolidated review report — consistent with the ₹1.93 Cr standalone-vs-consolidated PAT gap.
Informational and educational content only. Not investment advice.